| Basics |
| Company: |
Dyne Therapeutics, Inc. |
| IPO Date: |
September 17, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.43B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.53 | 3.22%
|
| Avg Daily Range (30 D): |
$0.60 | 3.73%
|
| Avg Daily Range (90 D): |
$0.76 | 3.19%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.53M |
| Avg Daily Volume (30 D): |
2.12M |
| Avg Daily Volume (90 D): |
1.22M |
| Trade Size |
| Avg Trade Size (Sh.): |
82 |
| Avg Trade Size (Sh.) (30 D): |
108 |
| Avg Trade Size (Sh.) (90 D): |
85 |
| Institutional Trades |
| Total Inst.Trades: |
1,439 |
| Avg Inst. Trade: |
$2.67M |
| Avg Inst. Trade (30 D): |
$3M |
| Avg Inst. Trade (90 D): |
$2.95M |
| Avg Inst. Trade Volume: |
.12M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.16M |
| Avg Closing Trade (30 D): |
$3.09M |
| Avg Closing Trade (90 D): |
$3.43M |
| Avg Closing Volume: |
170.24K |
|
|
|
|
| News |
Jun 24, 2024 @ 11:30 AM
Dyne Therapeutics Presents New Preclinical Data De...
Source: Dyne Therapeutics, Inc.
|
Jun 13, 2024 @ 8:40 PM
Dyne Therapeutics Presents New Preclinical Data fo...
Source: Dyne Therapeutics, Inc.
|
Jun 12, 2024 @ 2:09 PM
Soft Inflation Data Boosts Small Caps, Real Estate...
Source: Piero Cingari
|
May 30, 2024 @ 11:30 AM
Dyne Therapeutics to Present at Jefferies Global H...
Source: Dyne Therapeutics, Inc.
|
May 28, 2024 @ 11:30 AM
Dyne Therapeutics Announces Closing of Public Offe...
Source: Dyne Therapeutics, Inc.
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-3.56
|
$-.96
|
$-.7
|
|
Diluted EPS
|
$-3.56
|
$-.96
|
$-.7
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -294.51M
|
$ -97.13M
|
$ -65.1M
|
|
Operating Income / Loss
|
$ -314.47M
|
$ -105.66M
|
$ -71.96M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 401.5M
|
$ -76.02M
|
$ 336.17M
|
|
PE Ratio
|
|
|
|
|
